This paper describes the program development and evaluation experience at the Toronto-Sunnybrook Regional Cancer Centre between September 1990 and September 1992, with the Home Oncology Model Evaluation Pilot Program (H.O.M.E.) This paper demonstreates that the H.O.M.E. was clinically feasible, that no situation arose to jeopardize patient safety and that patient treatment was not compromised by treating chemotherapy patients in the home environment. The program proved to be a benefit for individuals who were physically debilitated but who wished to continue their chemotherapy at home. The authors believe that the program design utilized is a model which can be used as a basis for planning home chemotherapy in other communities. Note: Th...
BACKGROUND: The national Cancer Reform Strategy recommends delivering care closer to home whenever p...
A major focus of current health policy in the United Kingdom is the development of services that mee...
Paolo Tralongo1, Francesco Ferraù2, Nicolò Borsellino3, Francesco Verderame4, ...
Escalating cancer rates and an increase in the complexity and duration of chemotherapy regimens have...
OBJECTIVE: The objective of this study was to evaluate feasibility, safety, perception, and costs of...
PURPOSE: The objective of this pilot study was to evaluate the feasibility of oncological home-hospi...
Purpose With an aging population in Norway, there is increasing pressure on healthcare to provide be...
International audienceHome Care (HC) services provide complex and coordinated medical and paramedica...
Lessons Learned Based on our criteria, most medications can be administered in the home setting. ...
Includes bibliographical references (pages 29-31)During the past twenty-five years, the role of chem...
Background: Recent policy and guidance has focused on chemotherapy services being offered closer to ...
8 p.International audienceIn recent years, following a rapid development of Home Care Services (HCS)...
Background: Home-hospitalization might be a patient-centred approach facing the increasing burden o...
Objective: The objective of this study was to evaluate feasibility, safety, perception, and costs of...
This thesis deals with chemotherapy at home which is the fruit of increasing cancer patients and suc...
BACKGROUND: The national Cancer Reform Strategy recommends delivering care closer to home whenever p...
A major focus of current health policy in the United Kingdom is the development of services that mee...
Paolo Tralongo1, Francesco Ferraù2, Nicolò Borsellino3, Francesco Verderame4, ...
Escalating cancer rates and an increase in the complexity and duration of chemotherapy regimens have...
OBJECTIVE: The objective of this study was to evaluate feasibility, safety, perception, and costs of...
PURPOSE: The objective of this pilot study was to evaluate the feasibility of oncological home-hospi...
Purpose With an aging population in Norway, there is increasing pressure on healthcare to provide be...
International audienceHome Care (HC) services provide complex and coordinated medical and paramedica...
Lessons Learned Based on our criteria, most medications can be administered in the home setting. ...
Includes bibliographical references (pages 29-31)During the past twenty-five years, the role of chem...
Background: Recent policy and guidance has focused on chemotherapy services being offered closer to ...
8 p.International audienceIn recent years, following a rapid development of Home Care Services (HCS)...
Background: Home-hospitalization might be a patient-centred approach facing the increasing burden o...
Objective: The objective of this study was to evaluate feasibility, safety, perception, and costs of...
This thesis deals with chemotherapy at home which is the fruit of increasing cancer patients and suc...
BACKGROUND: The national Cancer Reform Strategy recommends delivering care closer to home whenever p...
A major focus of current health policy in the United Kingdom is the development of services that mee...
Paolo Tralongo1, Francesco Ferraù2, Nicolò Borsellino3, Francesco Verderame4, ...